Authors

Weight Loss Drugs On the Horizon: What Pharmacists Should Know

Expanding Roles for Pharmacy Technicians in Ambulatory Oncology

Jessica Davis, PharmD, BCOP highlights the role of pharmacy technicians in ambulatory oncology clinic settings.

Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapies

Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.

Neuriva: A Closer Look at the Efficacy and Safety of this Popular Supplement

US Supreme Court Undercuts Long-Standing Judicial Deference to Administrative Agencies

Ruling potentially affects federal ability to regulate pharmacy.

Striking the Balance: Evidence-Based versus Defensive Medicine

Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding Rotation

Recognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.

Updates in Cancer Prevention and Screening for 2025: A Pharmacist Primer

Pharmacists play a vital role in cancer prevention and early detection by educating patients on risk factors, counseling on screening guidelines, and promoting adherence to evidence-based recommendations for common cancers, such as breast, cervical, colorectal, lung, prostate, and skin cancer.

Tar-200 Plus Anti–PD-1 Therapy Shows Promising Neoadjuvant Activity in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Andrea Necchi, MD, shared SunRISe-4 primary results demonstrating higher pathologic response and relapse-free survival rates with TAR-200 plus sacituzumab compared with checkpoint inhibitor monotherapy, with no new safety signals observed.

Bispecifics, CAR T Cells Among Most Exciting Recent Advances in Hematologic Malignancies

Expert notes significant advances in the treatment of multiple myeloma, large B cell lymphomas, and acute myeloid leukemia, during a presentation at HOPA 2023 Annual Conference.

Happy New Year from The Tell-Tale Heart!

Hypertension: A Silent Killer Requiring Novel Therapies

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

A Dose of Inspiration: Celebrating the Pharmacist-Patient Relationship During Patient Experience Week

No matter what role you are in as a pharmacist, no matter where you work or how long you have been practicing, understand that making a difference in the life of a patient matters.

Drawn to Understand: How Culturally Tailored Education Empowers Patients With Type 1 Diabetes

Simplifying complex information through illustrations has consistently helped patients feel that managing type 1 diabetes is achievable.

Targeting Tumors: New Weapons in Gastrointestinal Cancer Therapy

Recent advances in GI oncology offer new treatment options for colorectal and pancreatic cancers, enhancing patient care and pharmacist roles in management.

Condition Watch: Diabetes

Standard of Care: The No. 1 Priority to Ensure Success in Pharmacy Practice’s Future

SOC emphasizes adaptability and individual professional judgment without compromising quality, as individuals are held to the standard and expertise of their practice area.

FDA Approves Milestone Oral Therapy for Adults With Thalassemia, Anemia

The FDA approved mitapivat, the first oral therapy for thalassemia due to anemia, offering hope for patients with transfusion-dependent and non–transfusion-dependent forms.

Supporting Access to Precision Medicine in Community Care Settings

Precision medicine transforms cancer care, enhancing patient outcomes through targeted therapies, yet faces challenges in community access and biomarker testing.

Project Optimus and Its Impact on the Oncology Treatment Landscape

Project Optimus transforms cancer treatment by optimizing dosing strategies, enhancing efficacy, and reducing toxicities in modern therapies.

The Evolving Pharmacist Role in HER2-Negative Adjuvant Breast Cancer Therapy

Julia Ziegengeist, PharmD, BCOP offers insights for pharmacists navigating adjuvant and neoadjuvant treatment of breast cancer.

AUC 5 vs AUC 6: MUSC Study Highlights the Trade-offs in Neoadjuvant Breast Cancer Treatment

Lacy La Fever, PharmD, MS, discussed outcomes associated with different carboplatin AUC dosing strategies.

Updates in Treatment of Unresectable Hepatocellular Carcinoma

This review examines the mechanisms of therapy, summarizes the existing literature, and highlights the evolving treatment options for unresectable hepatocellular carcinoma.

Paxlovid’s Double-Edged Sword: Treating COVID-19 and the Risk of Viral Load Rebound

The conversation of VLR has sparked a discussion as to whether or not other COVID-19 treatment agents are associated with a surge in symptoms and if so, how those agents compare with the rebound effect of nirmatrelvir/ritonavir.

Specialty Pharmacies Can Dispense the Emotional Script to Support Patients

A human-first support model helped boost adherence and outcomes, proving emotional connection is key to specialty medication success.

The Controversial 340B Rebate Pilot Program Is Moving Forward

HRSA moves forward with the 340B Rebate Model Pilot Program, raising concerns among health care providers about financial impacts and operational challenges.

Medication Meltdown: Unpacking Drug Shortages

Pharmacy staff can be instrumental members of shortage management teams.

Pharmacists Play a Unique Role in Creating Clean Sports

A strong knowledge of pharmacology and clinical pharmacotherapeutics is essential for sports pharmacists, enabling them to support athletes' overall health while ensuring compliance with anti-doping regulations.